Sex differences in hepatocellular carcinoma indicated BEX4 as a potential target to improve efficacy of lenvatinib plus immune checkpoint inhibitors
— · container not stated · 2022
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
· OpenAlex · work · 2022
Crossref supplies no abstract for this record; none is generated here.
Open the resolved locator · 10.7150/jca.73051
Metadata licence: OpenAlex metadata (CC0)